Variable clinical features of patients with Fabry disease and outcome of enzyme replacement therapy-Reference-Cited by-同舟云学术

Variable clinical features of patients with Fabry disease and outcome of enzyme replacement therapy

Published:2021-03 Issue: Volume:26 Page:100700
ISSN:2214-4269
Container-title:Molecular Genetics and Metabolism Reports
language:en
Short-container-title:Molecular Genetics and Metabolism Reports

Author:

Dutra-Clarke Marina,Tapia Daisy,Curtin Emily,Rünger Dennis,Lee Grace K.,Lakatos Anita,Alandy-Dy Zyza,Freedkin Linda,Hall Kathy,Ercelen Nesrin,Alandy-Dy Jousef,Knight Margaret,Pahl Madeleine,Lombardo Dawn,Kimonis Virginia

Funder

Clinical and Translational Science Institute, University of California, San Francisco

Sanofi Genzyme

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology

Reference57 articles.

1. Enzymatic defect in Fabry’s disease. Ceramidetrihexosidase deficiency;Brady;N Engl J Med.,1967

2. Exploring cells with a centrifuge;Duve;Science.,1975

3. Prevalence of lysosomal storage disorders;Meikle;JAMA.,1999

4. Alpha-galactosidase A deficiency: Fabry disease;Desnick,2001

5. Newborn screening for lysosomal storage disorders;Matern;Semin. Perinatol.,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fabry disease management: Current status, therapeutic challenges, and future horizons in drug delivery and artificial intelligence assisted diagnosis;Journal of Drug Delivery Science and Technology;2024-10

2. Neuropathy and pain in Fabry disease;Rare Disease and Orphan Drugs Journal;2024-07-08

3. Measuring health related quality of life (HRQoL) in Lysosomal Storage Disorders (LSDs): a rapid scoping review of available tools and domains;Orphanet Journal of Rare Diseases;2024-07-04

4. Assessing Osteopenia and Osteoporosis with Dual-energy X-ray Absorptiometry Studies in Fabry Disease;2024-07-01

5. Expanding the Neurological Phenotype of Anderson–Fabry Disease: Proof of Concept for an Extrapyramidal Neurodegenerative Pattern and Comparison with Monogenic Vascular Parkinsonism;Cells;2024-06-29